O. 'brien, S. Del-giglio, A. Keating, and M. , Advances in the biology and treatment of B-cell chronic lymphocytic leukemia, Blood, vol.85, pp.307-325, 1995.

N. Chiorazzi, Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells, Best Practice & Research Clinical Haematology, vol.20, issue.3, pp.399-413, 2007.
DOI : 10.1016/j.beha.2007.03.007

B. T. Messmer, D. Messmer, S. L. Allen, J. E. Kolitz, P. Kudalkar et al., In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells, Journal of Clinical Investigation, vol.115, issue.3, pp.755-64, 2005.
DOI : 10.1172/JCI23409DS1

P. Ghia, P. Circosta, C. Scielzo, A. Vallario, A. Camporeale et al., Differential Effects on CLL Cell Survival Exerted by Different Microenvironmental Elements, Curr Top Microbiol Immunol, vol.294, pp.135-180, 2005.
DOI : 10.1007/3-540-29933-5_8

F. Caligaris-cappio and T. J. Hamblin, B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather, Journal of Clinical Oncology, vol.17, issue.1, pp.399-408, 1999.
DOI : 10.1200/JCO.1999.17.1.399

P. E. Patten, A. G. Buggins, J. Richards, A. Wotherspoon, J. Salisbury et al., CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment, Blood, vol.111, issue.10, 2008.
DOI : 10.1182/blood-2007-08-108605

J. G. Giri, M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein et al., Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15, Embo J, vol.13, pp.2822-2852, 1994.

T. R. Malek, The Biology of Interleukin-2, Annual Review of Immunology, vol.26, issue.1, 2007.
DOI : 10.1146/annurev.immunol.26.021607.090357

J. Parrish-novak, S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher et al., Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function, Nature, vol.408, issue.10, pp.57-63, 2000.

B. H. Nelson and D. M. Willerford, Biology of the Interleukin-2 Receptor, Adv Immunol, vol.70, issue.11, pp.1-81, 1998.
DOI : 10.1016/S0065-2776(08)60386-7

J. X. Lin and W. J. Leonard, The role of Stat5a and Stat5b in signaling by IL-2 family cytokines, Oncogene, vol.19, issue.21, pp.2566-76, 2000.
DOI : 10.1038/sj.onc.1203523

R. N. Damle, F. Ghiotto, A. Valetto, E. Albesiano, F. Fais et al., B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes, Blood, vol.99, issue.11, pp.4087-93, 2002.
DOI : 10.1182/blood.V99.11.4087

T. Decker, F. Schneller, M. Kronschnabl, T. Dechow, G. B. Lipford et al., Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells, Experimental Hematology, vol.28, issue.5, pp.558-68, 2000.
DOI : 10.1016/S0301-472X(00)00144-2

A. C. Fluckiger, P. Garrone, I. Durand, J. P. Galizzi, and J. Banchereau, Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes, Journal of Experimental Medicine, vol.178, issue.5, pp.1473-81, 1993.
DOI : 10.1084/jem.178.5.1473

J. Tomic, D. White, Y. Shi, J. Mena, C. Hammond et al., Sensitization of IL-2 Signaling through TLR-7 Enhances B Lymphoma Cell Immunogenicity, The Journal of Immunology, vol.176, issue.6, pp.3830-3839, 2006.
DOI : 10.4049/jimmunol.176.6.3830

T. Decker, F. Schneller, S. Hipp, C. Miething, T. Jahn et al., Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27, Leukemia, vol.16, issue.3, pp.327-361, 2002.
DOI : 10.1038/sj.leu.2402389

T. Tretter, M. Schuler, F. Schneller, U. Brass, M. Esswein et al., Direct Cellular Interaction with Activated CD4+T Cells Overcomes Hyporesponsiveness of B-Cell Chronic Lymphocytic Leukemiain Vitro, Cellular Immunology, vol.189, issue.1, pp.41-50, 1998.
DOI : 10.1006/cimm.1998.1360

H. Mellstedt and A. Choudhury, T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil, Cancer Immunology, Immunotherapy, vol.4, issue.2, pp.210-230, 2006.
DOI : 10.1007/s00262-005-0675-4

B. Jahrsdorfer, R. Jox, L. Muhlenhoff, K. Tschoep, A. Krug et al., Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN, J Leukoc Biol, vol.72, pp.83-92, 2002.

B. Jahrsdorfer, L. Muhlenhoff, S. E. Blackwell, M. Wagner, H. Poeck et al., B-Cell Lymphomas Differ in their Responsiveness to CpG Oligodeoxynucleotides, Clinical Cancer Research, vol.11, issue.4, pp.1490-1499, 2005.
DOI : 10.1158/1078-0432.CCR-04-1890

P. G. Longo, L. Laurenti, S. Gobessi, A. Petlickovski, M. Pelosi et al., The Akt signaling pathway determines the different proliferative capacity of, pp.110-130, 2007.

D. T. Jones, K. Ganeshaguru, R. J. Anderson, T. R. Jackson, K. R. Bruckdorfer et al., Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis, Blood, vol.101, issue.8, pp.3174-80, 2003.
DOI : 10.1182/blood-2002-07-2143

H. M. Lockyer, E. Tran, and B. H. Nelson, STAT5 Is Essential for Akt/p70S6 Kinase Activity during IL-2-Induced Lymphocyte Proliferation, The Journal of Immunology, vol.179, issue.8, pp.5301-5309, 2007.
DOI : 10.4049/jimmunol.179.8.5301

J. R. Bayascas and D. R. Alessi, Regulation of Akt/PKB Ser473 Phosphorylation, Molecular Cell, vol.18, issue.2, pp.143-148, 2005.
DOI : 10.1016/j.molcel.2005.03.020

I. Ringshausen, F. Schneller, C. Bogner, S. Hipp, J. Duyster et al., Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta IL-2, regulatory T cells, and tolerance, Blood Nelson, B.H. J Immunol, vol.100, issue.172, pp.3741-3749, 2002.

S. Karray, T. Defrance, H. Merle-beral, J. Banchereau, P. Debre et al., Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells, Journal of Experimental Medicine, vol.168, issue.1, pp.85-94, 1988.
DOI : 10.1084/jem.168.1.85

M. R. Rezvany, M. Jeddi-tehrani, H. Wigzell, A. Osterborg, and H. Mellstedt, Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia, Blood, vol.101, issue.3, pp.1063-70, 2003.
DOI : 10.1182/blood-2002-03-0746

M. Beyer, M. Kochanek, K. Darabi, A. Popov, M. Jensen et al., Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine, Blood, vol.106, issue.6, pp.2018-2043, 2005.
DOI : 10.1182/blood-2005-02-0642

L. Granziero, P. Ghia, P. Circosta, D. Gottardi, G. Strola et al., Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia, Blood, vol.97, issue.9, pp.2777-83, 2001.
DOI : 10.1182/blood.V97.9.2777

P. Ghia, G. Strola, L. Granziero, M. Geuna, G. Guida et al., Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22, European Journal of Immunology, vol.32, issue.5, pp.1403-1416, 2002.
DOI : 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y

T. Decker, T. Flohr, P. Trautmann, M. J. Aman, W. Holter et al., Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia, Blood, vol.86, pp.1115-1138, 1995.

F. Caligaris-cappio and P. Ghia, Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease?, Journal of Clinical Oncology, vol.26, issue.27, pp.4497-503, 2008.
DOI : 10.1200/JCO.2007.15.4393

C. Pepper, T. T. Lin, G. Pratt, S. Hewamana, P. Brennan et al., Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers, Blood, vol.112, issue.9, pp.3807-3824, 2008.
DOI : 10.1182/blood-2008-05-157131

A. Cimmino, G. A. Calin, M. Fabbri, M. V. Iorio, M. Ferracin et al., miR-15 and miR-16 induce apoptosis by targeting BCL2, Proceedings of the National Academy of Sciences, vol.102, issue.39, pp.13944-13953, 2005.
DOI : 10.1073/pnas.0506654102

S. Willimott, M. Baou, K. Naresh, and S. D. Wagner, CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia, British Journal of Haematology, vol.101, issue.6, pp.721-753, 2007.
DOI : 10.1111/j.1365-2141.2007.06717.x

S. Zinkel, A. Gross, and E. Yang, BCL2 family in DNA damage and cell cycle control, Cell Death and Differentiation, vol.62, issue.8, pp.1351-1360, 2006.
DOI : 10.1016/j.molcel.2004.12.030

L. A. Smit, D. Y. Hallaert, R. Spijker, B. De-goeij, A. Jaspers et al., Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity, Blood, vol.109, issue.4, pp.1660-1668, 2007.
DOI : 10.1182/blood-2006-05-021683

D. Y. Hallaert, A. Jaspers, C. J. Van-noesel, M. H. Van-oers, A. P. Kater et al., c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches, Blood, vol.112, issue.13, pp.5141-5150, 2008.
DOI : 10.1182/blood-2008-03-146704

S. Deaglio and F. Malavasi, Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation, Haematologica, vol.94, issue.6, pp.752-758, 2009.
DOI : 10.3324/haematol.2009.006676

J. A. Engelman, Targeting PI3K signalling in cancer: opportunities, challenges and limitations, Nature Reviews Cancer, vol.16, issue.8, pp.550-62, 2009.
DOI : 10.1038/nrc2664